Human Pathology
Volume 39, Issue 8 , Pages 1239-1251 , August 2008

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

  • C. Blake Gilks, MD

      Affiliations

    • Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E3
    • Corresponding Author InformationCorresponding author. Pathology and Laboratory Medicine, Vancouver General Hospital, 1st Floor JPPN, Vancouver, BC, Canada V5Z 1M9.
    • ,
  • Diana N. Ionescu, MD

      Affiliations

    • Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E3
    • ,
  • Steve E. Kalloger, BSC

      Affiliations

    • Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E3
    • ,
  • Martin Köbel, MD

      Affiliations

    • Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E3
    • Institute of Pathology, Charité Hospital, Berlin, 10117 Germany
    • ,
  • Julie Irving, MD

      Affiliations

    • Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E3
    • ,
  • Blaise Clarke, MD

      Affiliations

    • Genetic Pathology Evaluation Centre of the Prostate Research Centre, Department of Pathology, Vancouver General Hospital and British Columbia Cancer Agency, and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E3
    • ,
  • Jennifer Santos, RN

      Affiliations

    • Department of Medical Oncology and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E6
    • ,
  • Nhu Le, PhD

      Affiliations

    • Cancer Control Research, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 1L3
    • ,
  • Veronika Moravan

      Affiliations

    • Cancer Control Research, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 1L3
    • ,
  • Kenneth Swenerton, MD

      Affiliations

    • Department of Medical Oncology and Gynecology Tumour Group, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 4E6
    • ,
  • on behalf of the Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, Vancouver, BC

Received 12 October 2007 ,Revised 4 January 2008 ,Accepted 8 January 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0046-8177(08)00030-0

doi: 10.1016/j.humpath.2008.01.003

Human Pathology
Volume 39, Issue 8 , Pages 1239-1251 , August 2008

Article Tools

* Image Usage & Resolution